Canada markets open in 26 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1250-0.0150 (-10.71%)
At close: 03:20PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
2,744
2,668
1,608
1,342
Cost of Revenue
1,433
1,255
1,039
814.715
Gross Profit
1,311
1,413
568.441
526.859
Operating Expenses
Research Development
837.889
1,054
1,377
1,326
Selling General and Administrative
3,777
3,723
4,075
3,425
Total Operating Expenses
4,614
4,777
5,452
4,751
Operating Income or Loss
-3,303
-3,364
-4,884
-4,224
Interest Expense
1,236
822.213
416.057
121.556
Total Other Income/Expenses Net
-27.018
261.671
327.773
461.653
Income Before Tax
-4,496
-3,824
-4,850
-3,846
Income from Continuing Operations
-4,496
-3,824
-4,850
-3,846
Net Income
-4,322
-3,890
-4,605
-3,717
Net Income available to common shareholders
-4,322
-3,890
-4,605
-3,717
Basic EPS
-0.04
-0.03
-0.04
-0.03
Diluted EPS
-0.04
-0.03
-0.04
-0.03
Basic Average Shares
112,600
120,702
112,600
108,614
Diluted Average Shares
112,600
120,702
112,600
108,614